New approaches to cystic fibrosis

Hospital Practice

Volumn 36, Issue 1, 2001, Pages 25-37

  Moss, R B ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; ARTICLE; CYSTIC FIBROSIS; DISEASE EXACERBATION; GENE MUTATION; GENE THERAPY; INFECTION; INFLAMMATION; PATHOGENESIS;

EID: 0035863844     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.2001.11444081     Document Type: Article

References (12)

1. Use of aerosolized antibiotics in patients with cystic fibrosis
2. Cystic fibrosis
3. Improved survival in the Danish center-treated cystic fibrosis patients: Results of aggressive treatment
4. Estimating effectiveness in an observational study: A case study of dornase alfa in cystic fibrosis. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis
5. Therapies aimed at airway inflammation in cystic fibrosis
6. Cystic fibrosis: Pathogenesis, pulmonary infection, and treatment
7. Management of pulmonary disease in patients with cystic fibrosis
8. Nutritional assessment and management in cystic fibrosis: A consensus report. The Consensus Committee
9. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis inhaled Tobramycin Study Group
10. Toward cystic fibrosis gene therapy
11. The genesis of cystic fibrosis lung disease
12. Cystic fibrosis: Genotypic and phenotypic variations